Tkasama T

Tkasama T


Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 November 2022 in Biosensors
Verified
Journal Article
Open access
PDF file
PGPANPAN GAO
PANPAN GAO
TTTkasama T
Tkasama T
JSJungchan Shin
Jungchan Shin
YHYixuan Huang
Yixuan Huang
RMRyo Miyake
Ryo Miyake
Laser-induced graphene (LIG) has been applied in many different sensing devices, from mechanical sensors to biochemical sensors. In particular, LIG fabricated on paper (PaperLIG) shows great promise for preparing cheap, flexible, and disposable biosensors. Distinct from the fabrication of LIG on polyimide, a two-step process is used for the fabrication of PaperLIG. In this study, firstly, a highly conductive PaperLIG is fabricated. Further characterization of PaperLIG confirmed that it was suitable for developing biosensors. Subsequently, the PaperLIG was used to construct a biosensor by immobilizing glucose oxidase, aminoferrocene, and Nafion on the surface. The developed glucose biosensor could be operated at a low applied potential (−90 mV) for amperometric measurements. The as-prepared biosensor demonstrated a limit of detection of (50–75 µM) and a linear range from 100 µM to 3 mM. The influence of the concentration of the Nafion casting solution on the performance of the developed biosensor was also investigated. Potential interfering species in saliva did not have a noticeable effect on the detection of glucose. Based on the experimental results, the simple-to-prepare PaperLIG-based saliva glucose biosensor shows great promise for application in future diabetes management.

7 June 2006 in Physical Review B
Verified
Journal Article
Closed access
PDF file
TTTkasama T
Tkasama T
YMY. Muraoka
Y. Muraoka
TIT. Idogaki
T. Idogaki
The mixed-spin axial next-nearest-neighbor Ising model, in which spin S=1 and spin μ=1∕2 ferromagnetic layers are stacked along the c axis alternately, is studied by using the molecular field approximation (MFA) and Monte Carlo (MC) simulation. The finite-temperature magnetic phase diagram obtained by the MFA shows a partially disordered phase (PDP) and the crossover behavior between two PDPs of periodicity 4, one including paramagnetic S spins and the other including paramagnetic μ spins. The appearance of the PDP and the crossover behavior predicted by the MFA are confirmed by MC simulation. The crossover behavior of the PDP is a coupled effect between the mixed spin and the frustration of the exchange interactions.

19 June 2019 in The Analyst
Verified
Journal Article
Closed access
PDF file
KNKeine Nishiyama
Keine Nishiyama
TTTkasama T
Tkasama T
SNSeiya Nakamata
Seiya Nakamata
KIKoya Ishikawa
Koya Ishikawa
DODaisuke Onoshima
Daisuke Onoshima
MTManabu Tokeshi
Manabu Tokeshi
We present an ultrasensitive immunoassay system for disease biomarkers utilizing the immuno-wall device and an enzymatic amplification reaction. The immuno-wall device consisted of 40 microchannels, each of which contained an antibody-modified wall-like structure along the longitudinal axis of the microchannel. The wall was fabricated with a water-soluble photopolymer containing streptavidin by photolithography, and biotinylated capture antibodies were immobilized on the sides through streptavidin–biotin interaction. For an assay, introducing the target biomarker and secondary and labeled antibodies produced a sandwich complex anchored on the sides of the wall. A conventional immuno-wall device uses a fluorescence-labeled antibody as a labeling antibody. To achieve an ultrasensitive detection of a trace biomarker, we used an enzyme label and amplified the signal with the enzymatic reaction with a fluorogenic substrate in the microchannel. The highest signal/background ratio was obtained by using alkaline phosphatase-labeled antibody and 9H-(1,3-dichloro-9,9-dimethylacridin-2-one-7-yl) phosphate. To evaluate the device performance, we detected human C-reactive protein (CRP) as a model biomarker. The detection limit (LOD) of CRP in phosphate-buffered saline was 2.5 pg mL−1 with a sample volume of 0.25 μL. This LOD was approximately 3 orders of magnitude lower than that obtained with fluorescent-dye (DyLight 650)-labeled antibody. In addition, the present device provided a wide detection range of 0.0025–10 ng mL−1 for CRP. We successfully developed an ultrasensitive immunoassay system with simple operation and only a small sample volume.

23 August 2024 in Micromachines
Verified
Journal Article
Open access
PDF file
TSTOMOMI SATO
TOMOMI SATO
KMKoji Masuda
Koji Masuda
CSChikako Sano
Chikako Sano
KMKeiji Matsumoto
Keiji Matsumoto
Hidetoshi NumataHidetoshi Numata
Hidetoshi Numata
RMRyo Miyake
Ryo Miyake
Microreactor technologies have emerged as versatile platforms with the potential to revolutionize chemistry and materials research, offering sustainable solutions to global challenges in environmental and health domains. This survey paper provides an in-depth review of recent advancements in microreactor technologies, focusing on their role in facilitating accelerated discoveries in chemistry and materials. Specifically, we examine the convergence of microfluidics with machine intelligence and automation, enabling the exploitation of the cyber-physical environment as a highly integrated experimentation platform for rapid scientific discovery and process development. We investigate the applicability and limitations of microreactor-enabled discovery accelerators in various chemistry and materials contexts. Despite their tremendous potential, the integration of machine intelligence and automation into microreactor-based experiments presents challenges in establishing fully integrated, automated, and intelligent systems. These challenges can hinder the broader adoption of microreactor technologies within the research community. To address this, we review emerging technologies that can help lower barriers and facilitate the implementation of microreactor-enabled discovery accelerators. Lastly, we provide our perspective on future research directions for democratizing microreactor technologies, with the aim of accelerating scientific discoveries and promoting widespread adoption of these transformative platforms.

31 October 2021 in Micromachines
Verified
Journal Article
Open access
PDF file
TTTkasama T
Tkasama T
MSMiaomiao Sun
Miaomiao Sun
NKNoritada Kaji
Noritada Kaji
SAShin’ichi Akiyama
Shin’ichi Akiyama
YYYukio Yuzawa
Yukio Yuzawa
YBYoshinobu Baba
Yoshinobu Baba
This study developed low-cost and highly sensitive immunoassay devices possessing the ability to rapidly analyze urine samples. Further, they can quantitatively detect three biomarkers indicating renal injury: monocyte chemotactic protein 1 (MCP-1), angiotensinogen (AGT), and liver-type fatty acid binding protein (L-FABP). The devices were used to successfully estimate the concentrations of the three biomarkers in urine samples within 2 min; the results were consistent with those obtained via conventional enzyme-linked immunosorbent assay (ELISA), which requires several hours. In addition, the estimated detection limits for the three biomarkers were comparable to those of commercially available ELISA kits. Thus, the proposed and fabricated devices facilitate high-precision and frequent monitoring of renal function.

16 November 2020 in PLOS ONE
Verified
Journal Article
Open access
PDF file
NYNaoyuki Yogo
Naoyuki Yogo
THTetsunari Hase
Tetsunari Hase
TTTkasama T
Tkasama T
KNKeine Nishiyama
Keine Nishiyama
NONaoya Ozawa
Naoya Ozawa
YHYoshinori Hasegawa
Yoshinori Hasegawa
Detecting molecular targets in specimens from patients with lung cancer is essential for targeted therapy. Recently, we developed a highly sensitive, rapid-detection device (an immuno-wall device) that utilizes photoreactive polyvinyl alcohol immobilized with antibodies against a target protein via a streptavidin–biotin interaction. To evaluate its performance, we assayed epidermal growth factor receptor (EGFR) mutations, such as E746_A750 deletion in exon 19 or L858R substitution in exon 21, both of which are common in non-small cell lung cancer and important predictors of the treatment efficacy of EGFR tyrosine kinase inhibitors. The results showed that in 20-min assays, the devices detected as few as 1% (E746_A750 deletion) and 0.1% (L858R substitution) of mutant cells. Subsequent evaluation of detection of the mutations in surgically resected lung cancer specimens from patients with or without EGFR mutations and previously diagnosed using commercially available, clinically approved genotyping assays revealed diagnostic sensitivities of the immuno-wall device for E746_A750 deletion and L858R substitution of 85.7% and 87.5%, respectively, with specificities of 100% for both mutations. These results suggest that the immuno-wall device represents a good candidate next-generation diagnostic tool, especially for screening of EGFR mutations.